Learn More
  • Arnt F. A. Schellekens, K. P. Grootens, C. Neef, Kris L. L. Movig, J. K. Buitelaar, B. Ellenbroek +1 other
  • 2010
INTRODUCTION Dysfunction of brain dopamine systems is involved in various neuropsychiatric disorders. Challenge studies with dopamine receptor agonists have been performed to assess dopamine receptor functioning, classically using the release of growth hormone (GH) from the hindbrain as primary outcome measure. The objective of the current study was to(More)
  • 1